Associations between hemodialysis access type and clinical outcomes: a systematic review

P Ravani, SC Palmer, MJ Oliver… - Journal of the …, 2013 - journals.lww.com
Clinical practice guidelines recommend an arteriovenous fistula as the preferred vascular
access for hemodialysis, but quantitative associations between vascular access type and …

Genome-wide association study identifies susceptibility loci for IgA nephropathy

…, GM Ghiggeri, M Bodria, F Lugani, P Ravani… - Nature …, 2011 - nature.com
We carried out a genome-wide association study of IgA nephropathy, a major cause of kidney
failure worldwide. We studied 1,194 cases and 902 controls of Chinese Han ancestry, with …

Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

…, A Amore, L Peruzzi, R Coppo, M Salvadori, P Ravani… - Nature …, 2014 - nature.com
We performed a genome-wide association study (GWAS) of IgA nephropathy (IgAN), the most
common form of glomerulonephritis, with discovery and follow-up in 20,612 individuals of …

[HTML][HTML] Vitamin D levels and patient outcome in chronic kidney disease

P Ravani, F Malberti, G Tripepi, P Pecchini, S Cutrupi… - Kidney international, 2009 - Elsevier
Vitamin D deficiency has been linked to cardiovascular disease and early mortality in patients
on hemodialysis; however, it is not known if the same association exists at earlier stages of …

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

P Ravani, G Tripepi, F Malberti, S Testa… - Journal of the …, 2005 - journals.lww.com
High plasma asymmetrical dimethylarginine (ADMA) signals endothelial dysfunction and
atherosclerosis in the general population and predicts mortality in ESRD. The relationship …

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

…, B Sprangers, DC Cattran, H Reich, Y Pei, P Ravani… - Nature …, 2023 - nature.com
IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular
deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-…

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease

…, M Tonelli, AX Garg, F Pellegrini, P Ravani… - Annals of internal …, 2010 - acpjournals.org
Background: Previous meta-analyses suggest that treatment with erythropoiesis-stimulating
agents (ESAs) in chronic kidney disease (CKD) increases the risk for death. Additional …

[HTML][HTML] Renal outcome in patients with congenital anomalies of the kidney and urinary tract

S Sanna-Cherchi, P Ravani, V Corbani, S Parodi… - Kidney international, 2009 - Elsevier
Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) are a major cause of
morbidity in children. We measured the risk of progression to end-stage renal disease in 312 …

Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography

MT James, WA Ghali, ML Knudtson, P Ravani… - Circulation, 2011 - Am Heart Assoc
Background— Acute kidney injury (AKI) is associated with early mortality after percutaneous
coronary revascularization procedures, but its prognostic relevance to long-term clinical …

Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial

…, MC Mann, B Hemmelgarn, B Manns, P Ravani… - Jama, 2022 - jamanetwork.com
Importance The effect of glucocorticoids on major kidney outcomes and adverse events in IgA
nephropathy has been uncertain. Objective To evaluate the efficacy and adverse effects of …